Efficient Delivery of Lomitapide using Hybrid Membrane‐Coated Tetrahedral DNA Nanostructures for Glioblastoma Therapy
Advanced Materials · 2024-06 · 36 (24)
DOI: 10.1002/adma.202311760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 11.04.2024. Verfasst von Mingming Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, Ch…. Hauptthemen laut MEDLINE: Glioblastoma, DNA. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Chongqing.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most aggressive and prevalent primary malignant tumor of the central nervous system. Traditional chemotherapy has poor therapeutic effects and significant side effects due to drug resistance, the natural blood‐brain barrier (BBB), and nonspecific distribution, leading to a lack of clinically effective therapeutic drugs. Here, 1430 small molecule compounds are screened based on a high‐throughput drug screening platform and a novel anti‐GBM drug, lomitapide (LMP) is obtained. Furthermore, a bionic nanodrug delivery system (RFA NPs) actively targeting GBM is constructed, which mainly consists of tetrahedral DNA nanocages (tFNA NPs) loaded with LMP as the core and a folate‐modified erythrocyte–cancer cell–macrophage hybrid membrane (FRUR) as the shell. FRUR camouflage conferred unique features on tFNA NPs, including excellent biocompatibility, improved pharmacokinetic profile, efficient BBB permeability, and tumor targeting ability. The results show that the LMP RFA NPs exhibited superior and specific anti‐GBM activities, reduced off‐target drug delivery, prolonged lifespan, and has negligible side effects in tumor‐bearing mice. This study combines high‐throughput drug screening with biomimetic nanodrug delivery system technology to provide a theoretical and practical basis for drug development and the optimization of clinical treatment strategies for GBM treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, China.
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 211198, China.
- Jiangsu Provincial University Key Laboratory of Drug Discovery for Metabolic Inflammatory Diseases, China Pharmaceutical University, Nanjing, 211198, China.
ORCID-Profile: Mingming Song, Chang Liu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
- Key Laboratory of Natural Medicines, China Pharmaceutical University
- Project funded by China Postdoctoral Science Foundation
- Jiangsu Funding Program for Excellent Postdoctoral Talent
- Natural Science Foundation of Xinjiang Uygur Autonomous Region
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
Zitieren
APA
Song, M., Tian, J., Wang, L., Dong, S., Fu, K., Chen, S., & Liu, C. (2024). Efficient Delivery of Lomitapide using Hybrid Membrane‐Coated Tetrahedral DNA Nanostructures for Glioblastoma Therapy. Advanced Materials, 36(24). https://doi.org/10.1002/adma.202311760
Vancouver
Song M, Tian J, Wang L, Dong S, Fu K, Chen S, et al. Efficient Delivery of Lomitapide using Hybrid Membrane‐Coated Tetrahedral DNA Nanostructures for Glioblastoma Therapy. Advanced Materials. 2024;36(24). doi:10.1002/adma.202311760
BibTeX
@article{Song2024,
author = {Song, Mingming and Tian, Jiameng and Wang, Li and Dong, Shuqi and Fu, Kun and Chen, Siyu and Liu, Chang},
title = {Efficient Delivery of Lomitapide using Hybrid Membrane‐Coated Tetrahedral DNA Nanostructures for Glioblastoma Therapy},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {24},
doi = {10.1002/adma.202311760}
}
EUVIMED